Related Experiment Video
Updated: Aug 5, 2026
10:21
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Catecholamine-induced necrosis and hypertrophy. Hemodynamic factors
Advances in Myocardiology
|January 1, 1985
Summary
Different catecholamines cause varying degrees of heart damage in rats. Isoproterenol and dobutamine induced significant myocardial hypertrophy and necrosis, unlike norepinephrine and dopamine, suggesting hemodynamic factors play a role.
Area of Science:
- Cardiology
- Pharmacology
- Toxicology
Background:
- Catecholamines are critical for cardiovascular regulation.
- Certain catecholamines can induce adverse cardiac effects, including hypertrophy and necrosis.
- Understanding the differential effects of various catecholamines is crucial for clinical applications and safety.
Purpose of the Study:
- To compare the effects of different catecholamines on myocardial hypertrophy and necrosis in a rat model.
- To investigate the potential role of hemodynamic changes in catecholamine-induced cardiac pathology.
Main Methods:
- Rats were treated daily for 10 days with isoproterenol, dobutamine, norepinephrine, or dopamine.
- Myocardial hypertrophy was assessed by measuring biventricular weight and biventricular/body weight ratio.
- Necrosis was evaluated using enzyme histochemical techniques on heart tissue sections.
- Hemodynamic parameters (blood pressure, heart rate) were monitored.
Main Results:
- Isoproterenol and dobutamine treatments resulted in significant myocardial hypertrophy and necrosis.
- Norepinephrine and dopamine treatments did not induce hypertrophy or necrosis.
- Isoproterenol and dobutamine acutely lowered blood pressure and increased heart rate.
- Norepinephrine and dopamine acutely increased blood pressure.
Conclusions:
- The study demonstrates differential cardiotoxic effects among catecholamines.
- Hemodynamic alterations, particularly hypotension and tachycardia, may contribute to catecholamine-induced myocardial necrosis.
- Necrosis might be a precursor to the observed hypertrophy, highlighting a potential mechanism of catecholamine cardiotoxicity.
Related Concept Videos
01:29Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:26Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
01:16Cellular Injury IV: Necrosis
Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...